Société Citius Pharmaceuticals, Inc.
Actions
CTXR
US17322U2078
Recherche biotechnologique et médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
0,6319 USD | -4,26 % | -13,44 % | -16,47 % |
Métier
Nombre d'employés: 22
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Leonard Mazur
CEO | Chief Executive Officer | 79 | 01/07/13 |
Jaime Bartushak
DFI | Director of Finance/CFO | 57 | 27/11/17 |
Preeti Singh
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/22 |
Myron Czuczman
CTO | Chief Tech/Sci/R&D Officer | 65 | 14/07/20 |
Alan Lader
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/16 |
Gary Talarico
COO | Chief Operating Officer | 69 | 01/03/16 |
Myron Holubiak
BRD | Director/Board Member | 77 | 01/10/15 |
Ilanit Allen
IRC | Investor Relations Contact | - | 17/05/21 |
General Counsel | - | 10/02/22 | |
Paul Sowyrda
PRN | Corporate Officer/Principal | - | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Myron Holubiak
BRD | Director/Board Member | 77 | 01/10/15 |
Dennis McGrath
BRD | Director/Board Member | 67 | 07/02/23 |
Leonard Mazur
CEO | Chief Executive Officer | 79 | 01/07/13 |
Carol Webb
BRD | Director/Board Member | 78 | 01/03/16 |
Suren Dutia
BRD | Director/Board Member | 82 | 01/10/15 |
Eugene Holuka
BRD | Director/Board Member | 65 | 01/06/16 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 180 673 355 | 168 365 416 ( 93,19 %) | 0 | 93,19 % |
Coordonnées société
Citius Pharmaceuticals, Inc.
11 Commerce Drive 1st floor
07016, Cranford
+908 967 6677
http://www.citiuspharma.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-16,47 % | 114 M | |
+54,05 % | 58,71 Md | |
-2,02 % | 41,31 Md | |
+40,01 % | 39,2 Md | |
-10,22 % | 27,4 Md | |
+13,42 % | 26,55 Md | |
-21,60 % | 18,98 Md | |
+2,89 % | 12,51 Md | |
+22,40 % | 11,94 Md | |
+27,49 % | 12,08 Md |
- Bourse
- Actions
- Action CTXR
- Société Citius Pharmaceuticals, Inc.